На главную
Видео добавленное пользователем “ifpma”
IFPMA: Biotherapeutic medicines explained
 
03:53
This IFPMA video illustrates what biotherapeutics are all about. They are typically derived from living organisms and are made by genetically engineering DNA. A high level of precision is required in the commercial manufacturing process to produce a consistent product each time. Every step we take in the production of these medicines requires highly controlled testing to ensure consistent quality, safety, and efficacy. A must watch.
Просмотров: 3920 ifpma
Watch Out for False Friends (full version)
 
03:40
Every day, fake medicines find their way into online and physical pharmacies, hospitals, and street markets. This plague knows no borders. In the best case scenario, fake medicines leave patients with no side-effects but also without a cure. In many other cases, however, they can kill people. We have to get smarter than the criminals to put a stop to this silent public health threat. This video stars a genuine pill who explains the danger of fake medicines and their impact on our societies. Patients, nurses, doctors, pharmacists, carers, regulators, and policy makers need to be on the lookout, and everybody needs to better understand the danger of fake medicines and how to stay safe. Please help us raise awareness on fake medicines by sharing this video, tweeting it, talking about it, and showing it to the people that you care about... and tell us what you think about it. Copyright: IFPMA
Просмотров: 6999 ifpma
Never Stop Advancing -- Incremental Innovation
 
03:43
This video illustrates the value of innovation -- both revolutionary and incremental -- in the biopharmaceutical field. With a specific focus on incremental innovation, it explains how the continuous investments in R&D, and consequent advances in available treatments, have bettered the lives of millions patients all around the world.
Просмотров: 3603 ifpma
The Exciting Journey from Flu Virus to Vaccine
 
04:14
Ever wondered how your flu vaccine is made? Look no further. This video illustrates the most common way that flu vaccines are made using an egg-based manufacturing process that has been in existence for more than 70 years. For our expert take on flu vaccine, click here: https://www.youtube.com/watch?v=zJm5A29D1BU&feature=youtu.be
Просмотров: 3935 ifpma
Phelophepa Train of Hope
 
05:58
Просмотров: 1248 ifpma
Pharmacovigilance: Do your bit, play your part!
 
02:50
Pharmacovigilance is one of the key steps to ensuring the safety of all our medicines, including biotherapeutics and vaccines. It encourages an ongoing cycle of communication between patients, health professionals, regulatory authorities, and our biopharma industry which is responsible for the development, manufacture, and supply of medicines. Do your bit, play your part! www.ifpma.org and www.icn.ch
Просмотров: 653 ifpma
The Exciting Journey from Flu Virus to Vaccine- Surveillance activities
 
03:51
Ever wondered how your flu vaccine is made? Look no further. This video illustrates the different surveillance activities needed to target the right virus before the manufacturing process begins. For the manufacturing process, click here: http://www.ifpma.org/resource-centre/the-exciting-journey-from-flu-virus-to-vaccine-2/
Просмотров: 13607 ifpma
IFPMA Interviews on Mental & Neurological Disorders: Dr. Shekhar Saxena
 
08:48
Dr. Shekhar Saxena, Director, Department of Mental Health and Substance Abuse, World Health Organization, sits down with Mario Ottiglio, IFPMA, to discuss latest trends on mental & neurological disorders.
Просмотров: 1055 ifpma
IFPMA 'I am Innovation' with Spanish subtitle
 
02:42
Mr. Innovation takes you on a quick, under-3-minute journey to discover his beginnings, his major achievements in health and other fields, and major challenges ahead. How has innovation made strides in global health? Can innovation win the fight against life-threatening diseases? Watch and find out. 26th IFPMA Assembly on 31 October 2012.
Просмотров: 1030 ifpma
Annonce spéciale de l’IFPMA et DIA 4ème Conférence réglementaire en Afrique
 
02:47
Dakar - Sénégal 26 – 29 Avril 2015 Annonce spéciale – Ne manquez pas la 4e Conférence Réglementaire Africaine ! Caroline Mendy, en charge de la politique réglementaire au sein de l’IFPMA invite tous ceux désireux d’améliorer l’accès aux médicaments en Afrique et intéressés par les différentes questions inhérentes à l’environnement réglementaire de ce continent, à joindre l’IFPMA, la DIA et leurs partenaires à Dakar du 26 au 29 Avril 2015. Contribuez au succès de cette plateforme en partageant vos expériences et interrogations relative à la thématique ‘Vers une réglementation harmonisée en Afrique pour un meilleur accès aux médicaments’! Pour plus d’information, clickez ici http://www.diahome.org/Meetings-and-Training/Find-Meetings-and-Training/Meeting-Details.aspx?ProductID=3127823
Просмотров: 19715 ifpma
"I am Innovation" (© IFPMA 2012)
 
02:40
Mr. Innovation takes you on a quick, under-3-minute journey to discover his beginnings, his major achievements in health and other fields, and major challenges ahead. How has innovation made strides in global health? Can innovation win the fight against life-threatening diseases? Watch and find out.
Просмотров: 12445 ifpma
IFPMA 2014 Interview Series on “The R&D Challenges in tackling Ebola” with Dr Ripley Ballou, GSK
 
03:59
This IFPMA video interview with Ripley Ballou, who's in charge of GlaxoSmithKline's (GSK’s) Ebola vaccine program in Rixensart, Belgium, was recorded soon after Ebola scientists and representatives from companies and regulatory bodies met at the World Health Organization’s (WHO’s) headquarters in Geneva, Switzerland, 4-5 September, to discuss how to speed up clinical development of vaccines, a process that normally takes years. Dr Ripley Ballou, like many public health specialists, believes that vaccines will have an important role to play in stopping the catastrophic outbreak in West Africa, which has so far caused at least 6553 cases and more than 3000 deaths in Guinea, Sierra Leone, and Liberia. (Reported numbers; the real toll is known to be much higher.) (Geneva, 30 September 2014)
Просмотров: 914 ifpma
PHARMACEUTICAL INDUSTRY & GLOBAL HEALTH - IFPMA FACTS & FIGURES 2014
 
02:18
A ‘pharma by numbers’ video illustrating the key facts & figures that range from innovation in R&D to access to medicines and global health, and from the economic footprint to public private partnerships. This video is based on the IFPMA yearly flagship publication ‘PHARMACEUTICAL INDUSTRY & GLOBAL HEALTH - FACTS & FIGURES’ : http://www.ifpma.org/fileadmin/content/Publication/2014/IFPMA_-_Facts_And_Figures_2014.pdf
Просмотров: 19856 ifpma
IFPMA 2014 Interview Series with Dr Joan Awunyo-Akaba
 
04:54
Dr Joan Awunyo-Akaba: Representative of the civil society on the GAVI Alliance Board Immunization: The Missed Opportunity In this interview, Dr Joan Awunyo-Akaba, Gavi Civil Society Organizations (CSOs) Board Member gives her take on what “Immunization – the Missed Opportunity” is all about. She puts a special emphasis on how to reach that fifth child that is still not receiving the direly need immunization shots. By addressing immunization challenges, the international community can reduce the burden of vaccine-preventable diseases that affects the future of those children, sustain healthy communities, and reduce health disparities both within and across countries. Bio: Dr Awunyo-Akaba has a PhD in medical sociology from the University of Ghana Legon (2007). She is a community health development consultant; Founder and Executive Director of Future Generations International (FUGI), a Ghanaian based NGO on health promotion and development; and an expert in childhood immunisation advocacy; behaviour change communication; and water, sanitation, and hygiene. A registered nurse, she is involved in civil society organisational activities, and is currently the National Vice Chairperson of the Ghana Coalition of NGOs in Health. Joan also represents the national Health Coalition on the Ghana Health Services’ Gavi Consortium that assesses the eligibility and involvement of CSOs in immunisation and health systems strengthening; and is presently advocating for the establishment of a National Innovative Fund for Childhood Immunization that would ensure the sustainability of the EPI in Ghana when Gavi support ends.
Просмотров: 297 ifpma
How far have we come in the fight against Alzheimer's Disease?
 
04:01
What progress have we made in the fight against Alzheimer's Disease and dementia? What are the remaining challenges? And what role do you have to play in the fight? Find out this World Alzheimer's Month! More info: https://www.alz.co.uk/ http://www.doyoumindcampaign.org/ https://www.ifpma.org/
Просмотров: 336 ifpma
IFPMA @ Pre-ICDRA 2016- Vaccine, interrupted
 
04:37
Simplifying regulatory complexity for better products to be available to patients faster.
Просмотров: 11895 ifpma
IFPMA @ preICDRA2016 - What to expect?
 
02:19
As regulatory stakeholders from around the world meet at the 17th International Conference of Drug Regulatory Authorities (ICDRA) in Cape Town, South Africa from 27 November to 2 December 2016 (http://www.icdra.co.za/), an open #preICDRA2016 conference, titled “Patients Are Waiting: How Regulators Collectively Make a Difference” will be convened from the 27-28 November 2016 at the International Convention Centre (ICC) in Cape Town. Experts from IFPMA’s regulatory groups will be actively involved at Pre-ICDRA as speakers on important related sessions, such as the way forward for life-cycle management; stakeholders’ collaboration in emergency situations and others. IFPMA & IPASA will also co-organize a special event on November 26. For more: http://www.ifpma.org/events-2/icdra2016/
Просмотров: 221 ifpma
Making Natural Product Research Work: Frank Petersen
 
26:48
The Novartis experience in natural product research -- complexity, challenges and successful collaborations Frank Petersen -- Head of Natural Products Unit (Novartis Institutes for BioMedical Research)
Просмотров: 898 ifpma
Biopharmaceutical Innovation: the Complexity of the R&D Process
 
23:51
Presentation by Dr. Markus Boehringer, Head of External Innovation & Alliances CVM Diseases, F. Hoffmann-La Roche. Geneva Pharma Forum on Biopharmaceutical Innovation. 17 April 2012 at WIPO
Просмотров: 1059 ifpma
Pharmacovigilance (Spanish): Do your bit, play your part!
 
03:25
Pharmacovigilance is one of the key steps to ensuring the safety of all our medicines, including biotherapeutics and vaccines. It encourages an ongoing cycle of communication between patients, health professionals, regulatory authorities, and our biopharma industry which is responsible for the development, manufacture, and supply of medicines. Do your bit, play your part! www.ifpma.org and www.icn.ch
Просмотров: 225 ifpma
The threat of counterfeit medicines: interview with Cyntia Genolet
 
01:54
Ms Cyntia Genolet is IFPMA’s Policy Analyst, Regulatory & Health Policy and leads the organisation’s anti-counterfeiting portfolio. In this short interview, she gives a brief summary about the threat posed by counterfeit medicines and factors encouraging the trade of counterfeit medicines. In 2015, IFPMA is organising two workshops on counterfeit medicines in Asia and Africa. For more, click here: http://www.ifpma.org/global-health/counterfeits/ifpma-counterfeit-workshops.html
Просмотров: 24252 ifpma
What the IFPMA Assembly 2014 is all about
 
02:08
Riz Khan shows here the different topics that this year's Assembly will tackle with a special call to invest in healthier societies. The main themes will revolve around inclusiveness, sustainability, and innovation. The floor will be given to Hans Rosling, the man who makes statistics sing. The event will take place in New York City on November 4. To learn more about the event, please visit www.ifpmaassembly2014.org
Просмотров: 231 ifpma
Fake medicines: what are they? / Les faux médicaments: de quoi s’agit-ils?
 
07:03
Ms Cyntia Genolet, IFPMA’s Policy Analyst, Regulatory & Health Policy and leads the organisation’s anti-counterfeiting portfolio, together with Marc Gentilini, General Delegate of ‘Fondation Chirac’ give their take on what fake medicines are and how to curb their threat. For more on IFPMA Workshops on Counterfeit Medicine for 2015, click here: http://www.ifpma.org/global-health/counterfeits/ifpma-counterfeit-workshops.html
Просмотров: 238 ifpma
IFPMA highlight: From shortages to sustainable supply
 
02:17
Missed out on the conversation on what can be done to prevent shortages of medicines and vaccines? Watch the highlights here! You can also re-watch the full session here: http://bit.ly/2ruegnE Session flow: - Welcome and introduction by Thomas Cueni, IFPMA Director General - Introduction to medicines and vaccines shortages Anders Vinther, Chief Quality Officer, Sanofi Pasteur, and IFPMA Heads of Quality Group Chair - Panel session Luc Besançon, CEO, International Pharmaceutical Federation Ann Ottosen, Senior Contracts Manager, UNICEF Supply Division Anders Vinther, Chief Quality Officer, Sanofi Pasteur on behalf of IFPMA Tania Cernuschi, Technical Officer, Vaccine Pricing, Supply, Procurement, World Health Organization Moderated by Sukaina Virji. For more information, have a look at: - Infographic: What's behind medicines and vaccines shortages: http://www.ifpma.org/wp-content/uploads/2017/04/Sustainable-Supply-Infographic.pdf - Interview with Anders Vinther: https://www.youtube.com/watch?v=MbT7h3Gp8D0 - IFPMA website: http://www.ifpma.org Follow IFPMA on social media: Twitter: https://twitter.com/IFPMA (@IFPMA) LinkedIn: https://www.linkedin.com/company/ifpma
Просмотров: 5136 ifpma
IFPMA video highlight: Life-course immunization and prevention
 
02:28
IMMUNIZATION AND PREVENTION: A LIFE-COURSE APPROACH FOR A HEALTHY AND PRODUCTIVE AGEING POPULATION We are bringing together industry leaders, senior policymakers, and representations from the diplomatic community, as well as key global health stakeholders attending the World Health Assembly, an expert panel will discuss immunization and prevention, exploring how a life-course approach can contribute to a healthy and productive population. With the number of people aged 65 or older expected to triple to 1.5 billion by 2050, this is an increasing priority for policymakers and an issue that requires urgent progress. https://www.ifpma.org/events-2/wha70-ifpma-reception-special-focus-on-vaccines/
Просмотров: 111 ifpma
4HealthyHabits
 
03:34
The four main NCDs – cardiovascular diseases, cancer, chronic respiratory diseases and diabetes – kill three in five people worldwide, with 80% of NCD-related deaths occurring in low- and middle-income countries. While 50% of NCDs are avoidable, they share four main behavioural risk factors: tobacco use, harmful use of alcohol, insufficient physical activity, and unhealthy diet or obesity. Successful prevention of these deadly diseases largely depends on encouraging people to lead healthy lifestyle. Together, IFRC and IFMPA launched a global initiative, called ‘4 Healthy Habits’. This innovative partnership equips Red Cross and Red Crescent volunteers with information and tools to change behaviours, promote healthy lifestyles in communities around the world and ultimately reduce the rise of NCDs.
Просмотров: 454 ifpma
Launch of the African Global Health Leaders Fellowship at the Graduate Institute in Geneva
 
02:19
Sub-Saharan African countries have sustained unprecedented transformation and change in the last decade, including constant economic growth, a growing middle class, increased political stability, and a skilled workforce. Recognition must be given to these advances, even though challenges remain: Africa’s population is expected to constitute 25% of the global population in 2050 (16% in 2017) with a sharp increase in the youth population under 25. This will also put health systems increasingly under pressure. This event brings together emerging leaders from Ghana and Nigeria to discuss the achievements and challenges across the continent by raising some of the following questions: What are the most promising approaches for efficient healthcare systems in Africa? What are the challenges to achieve Universal Health Coverage (UHC)? How can health policy-making skills be strengthened in the region to meet the needs of the future? What are politically and economically feasible solutions to improve health security and sustain healthier societies? How can investment in education for health be fostered and African leaders supported so that they can effectively shape and tailor public health policies? These questions and more are precisely what the Global Health Centre at the Graduate Institute, the Centre on Global Health Security at Chatham House, and the IFPMA had in mind to invite you to discuss.
Просмотров: 96 ifpma
IFPMA 2016 Geneva Pharma Forum on Biotherapeutics - Long version
 
01:13:07
Watch what healthcare stakeholders and regulatory experts are saying today about the opportunities & challenges facing biotherapeutic medicines. On more details of this event, click here: http://www.ifpma.org/events-2/biotherapeutic-medicines-a-winning-formula-for-patients/
Просмотров: 101 ifpma
26th IFPMA Assembly Panel Discussion II, Geneva, October 31, 2012
 
55:54
Panel II: "Creative Innovation: Addressing Key Research Gaps" Ama de-Graft Aikins, Visiting Fellow, London School of Economics, Health Francis Gurry, Director General, World Intellectual Property Organization Trevor Mundel, President, Global Health Program, Gates Foundation Dhaval D Patel, Head, Novartis Institutes for BioMedical Research Europe, Novartis Bernard Pécoul, Executive Director, Drugs for Neglected Diseases Initiative Ulf Wiinberg, President and CEO, Lundbeck
Просмотров: 297 ifpma
Pharmacovigilance (French): Do your bit, play your part!
 
03:07
Pharmacovigilance is one of the key steps to ensuring the safety of all our medicines, including biotherapeutics and vaccines. It encourages an ongoing cycle of communication between patients, health professionals, regulatory authorities, and our biopharma industry which is responsible for the development, manufacture, and supply of medicines. Do your bit, play your part! www.ifpma.org and www.icn.ch
Просмотров: 79 ifpma
Video by Jon Pender, GlaxoSmithKline
 
08:29
IFPMA Geneva Pharma Forum: Access to antiretrovirals in developing countries: towards a new landscape?
Просмотров: 74 ifpma
"I am Innovation" (©IFPMA) (Portuguese subtitles)
 
02:40
Este vídeo sobre inovação explica, de uma forma rápida e fácil, como são feitos medicamentos inovadores e como impactam a vida dos pacientes e também quais são os principais desafios pela frente. Ficou curioso? Assista ao vídeo e comente! (Vídeo com legenda adaptada e produzido pela IFPMA - The International Federation of Pharmaceutical Manufacturers & Associations. Para ter acesso ao vídeo original, acesse https://www.youtube.com/watch?v=kwo4d5SYwwk).
Просмотров: 180 ifpma
From shortages to sustainable supply
 
01:47:07
This event looks at the complex supply chain management that can cause shortages of medicines and vaccines, as well as existing initiatives to pre-empt or mitigate supply distribution. Session flow: - Welcome and introduction by Thomas Cueni, IFPMA Director General - Introduction to medicines and vaccines shortages Anders Vinther, Chief Quality Officer, Sanofi Pasteur, and IFPMA Heads of Quality Group Chair - Panel session Luc Besançon, CEO, International Pharmaceutical Federation Ann Ottosen, Senior Contracts Manager, UNICEF Supply Division Anders Vinther, Chief Quality Officer, Sanofi Pasteur on behalf of IFPMA Tania Cernuschi, Technical Officer, Vaccine Pricing, Supply, Procurement, World Health Organization Moderated by Sukaina Virji, News Editor, Scrip and Pink Sheet. For more information, have a look at: - Infographic: What's behind medicines and vaccines shortages: http://www.ifpma.org/wp-content/uploads/2017/04/Sustainable-Supply-Infographic.pdf - Interview with Anders Vinther: https://www.youtube.com/watch?v=MbT7h3Gp8D0 - IFPMA website: http://www.ifpma.org Follow IFPMA on social media: Twitter: https://twitter.com/IFPMA (@IFPMA) LinkedIn: https://www.linkedin.com/company/ifpma
Просмотров: 1250 ifpma
IFPMA 2017 Interview Series: Experts take on 9th Asia Regulatory Conference - Toshiyoshi Tominaga
 
01:01
Hear the perspective of Toshiyoshi Tominaga, Pharmaceuticals & Medical Devices Agency, Japan, who attended the 9th Asia regulatory conference 6-7 April 2017 in Tokyo on ‘Optimizing Access to Medicines in Asia through Regulatory Excellence’. This is event that takes place every two years and offers a unique opportunity to exchange experiences and progressive views on key regulatory topics, as well as identifying focus areas for ongoing and future efforts to increase patient access to innovative therapies.
Просмотров: 18 ifpma
IFPMA @DIA Europe 2018 - Dr. Sarah Adam
 
02:03
IFPMA will be joining the 30th edition of the DIA Europe 2018. This year, we will come along our experts to give our takes in the Good Manufacturing Practices, Life Cycle Management of a Product, International Conference on Harmonization ICH sessions and many more. DIA Europe 2018 will give us an opportunity to learn about different initiatives, engage with our stakeholders, and give our perspectives in healthcare. Join us @DIA Europe! For more: http://www.diaglobal.org/en/flagship/euromeeting/about/conference
Просмотров: 45 ifpma
IFPMA 2017 Interview Series: Experts take on 9th Asia Regulatory Conference - Kathy Gardiner
 
00:58
Hear the perspective of Kathy Gardiner, Patient Advocate &Director of The Naked Gardiner Foundation, who attended the 9th Asia regulatory conference 6-7 April 2017 in Tokyo on ‘Optimizing Access to Medicines in Asia through Regulatory Excellence’. This is event that takes place every two years and offers a unique opportunity to exchange experiences and progressive views on key regulatory topics, as well as identifying focus areas for ongoing and future efforts to increase patient access to innovative therapies.
Просмотров: 63 ifpma
IFPMA Season's Greetings e-card
 
00:49
IFPMA Best wishes for the holiday season and a prosperous 2013
Просмотров: 323 ifpma
IFPMA Interviews on Mental & Neurological Disorders: Peter Hongaard
 
05:17
Peter Hongaard, Senior VP of External Scientific Affairs for Lundbeck, sits down with Mario Ottiglio, IFPMA, to discuss the research challenges in the mental & neurological disorders arena.
Просмотров: 108 ifpma
Interview with Anders Vinther on medicines & vaccines shortages
 
05:34
Must watch! Ahead of World Immunization Week 2017 we had a chat with Anders Vinther, Chief Quality Officer at Sanofi Pasteur and Chair of IFPMA Vaccines Heads of Quality group, on medicine and vaccine shortages. Hear him discuss the root causes, prevention and the significance of the issue. Find out more about shortages at our event on 28 April 2017, Geneva Pharma Forum. #WIW2017 Please RSVP to info@ifpma.org for the event.
Просмотров: 13715 ifpma
IFPMA 2017 Interview Series: IFPMA DG Thomas Cueni’s Take on Pat-INFORMED
 
01:15
Thomas Cueni, IFPMA Director General gives his take on Pat-INFORMED: A joint WIPO-IFPMA initiative launched on 3 October 2017. For more, click here: https://www.ifpma.org/events-2/wipoga49-panel-discussion-on-patent-information-initiative-for-medicines-pat-informed/
Просмотров: 113 ifpma
Open innovation to improve healthcare
 
13:53
by Mr. Robert DeBerardine Global Head of Patents, sanofi-aventis [Side Event at WIPO General Assemblies on 22nd September 2010]
Просмотров: 376 ifpma
26th IFPMA Assembly - Panel Discussion I, Geneva, October 31, 2012
 
54:00
Panel I: "Innovation Today: Treading New Ground to Meet Global Health Needs" Cary Adams, CEO, Union for International Cancer Control Nigel Darby, Vice President of Biotechnologies, Chief Technology Officer GE Healthcare David Khayat, Professor and Head of Medical Oncology, Pitié-Salpêtrière Hospital John Lechleiter, Chairman, President, and CEO, Eli Lilly & Company Mary Lou Valdez, Associate Commissioner for International Programs, U.S. Food and Drug Administration
Просмотров: 298 ifpma
IFPMA Interviews on Mental & Neurological Disorders: Norman Sartorius
 
06:12
Norman Sartorius, President of the Association for the Improvement of Mental Health Programmes, sits down with Ali Karami-Ruiz, IFPMA, to discuss social challenges to fight mental & neurological disorders.
Просмотров: 413 ifpma
Technical Briefing on Biodiversity - Introduction
 
06:22
by Axel Braun Geneva Pharma Forum: on 24 November 2009
Просмотров: 28 ifpma
IFPMA 2016 interview series on 'The R&D challenges in tackling Zika virus'
 
04:15
Dr Ted Tsai, a vaccine expert from Takeda, made available by IFPMA talks here about the outcome of the three day closed consultation with World Health Organization that took place 7-9 March 2016 in Geneva. He speaks about where we are with research in the fight against Zika virus: what are the current challenges in terms of making swiftly available effective and safe vaccines, therapeutics, diagnostics, and vector control. For more here:
Просмотров: 1651 ifpma
Special IFPMA-DIA Announcement: 4th African Regulatory Conference 2015
 
02:45
A conference you should not miss! Caroline Mendy, IFPMA Regulatory Policy Manager, invites those interested in access to medicines and regulatory issues in and for Africa to join the IFPMA and Drug Information Association, in Dakar, 26 -- 29 April 2015. Have your say on 'Moving towards Regulatory Harmonisation to enhance Access to Medicines in Africa'! For more information, http://www.diahome.org/en-GB/Meetings-and-Training/Find-Meetings-and-Training/Meeting-Details.aspx?ProductID=3658765
Просмотров: 23425 ifpma
Young innovators in the spotlight: Mr. Bright Simons
 
15:49
President, mPedigree Network
Просмотров: 893 ifpma